U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Liver and intrahepatic bile duct neoplasm

MedGen UID:
232599
•Concept ID:
C1333976
•
Neoplastic Process
Synonyms: epithelial hepatic and intrahepatic bile duct neoplasm; Hepatic and Intrahepatic Bile Duct Neoplasm; hepatic and intrahepatic bile duct neoplasm; liver and intrahepatic bile duct epithelial neoplasm; Liver and Intrahepatic Bile Duct Neoplasm; liver and intrahepatic bile duct neoplasm; Liver Neoplasm; liver neoplasm; liver neoplasm (disease); liver tumor; liver tumour; neoplasm of liver; tumor of liver; tumour of liver
 
Monarch Initiative: MONDO:0024477

Definition

A benign or malignant neoplasm that affects the liver parenchyma or intrahepatic bile ducts. Representative examples of benign neoplasms include hepatocellular adenoma, and bile duct adenoma. Representative examples of malignant neoplasms include hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and lymphoma. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVLiver and intrahepatic bile duct neoplasm

Professional guidelines

PubMed

Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians.
Moris D, Palta M, Kim C, Allen PJ, Morse MA, Lidsky ME
CA Cancer J Clin 2023 Mar;73(2):198-222. Epub 2022 Oct 19 doi: 10.3322/caac.21759. PMID: 36260350
Clinical treatment of cholangiocarcinoma: an updated comprehensive review.
Elvevi A, Laffusa A, Scaravaglio M, Rossi RE, Longarini R, Stagno AM, Cristoferi L, Ciaccio A, Cortinovis DL, Invernizzi P, Massironi S
Ann Hepatol 2022 Sep-Oct;27(5):100737. Epub 2022 Jul 7 doi: 10.1016/j.aohep.2022.100737. PMID: 35809836
Pathogenesis, diagnosis, and management of cholangiocarcinoma.
Ilyas SI, Gores GJ
Gastroenterology 2013 Dec;145(6):1215-29. Epub 2013 Oct 15 doi: 10.1053/j.gastro.2013.10.013. PMID: 24140396Free PMC Article

Recent clinical studies

Etiology

Pathology of Cholangiocarcinomas.
Guedj N
Curr Oncol 2022 Dec 26;30(1):370-380. doi: 10.3390/curroncol30010030. PMID: 36661679Free PMC Article
Clinical treatment of cholangiocarcinoma: an updated comprehensive review.
Elvevi A, Laffusa A, Scaravaglio M, Rossi RE, Longarini R, Stagno AM, Cristoferi L, Ciaccio A, Cortinovis DL, Invernizzi P, Massironi S
Ann Hepatol 2022 Sep-Oct;27(5):100737. Epub 2022 Jul 7 doi: 10.1016/j.aohep.2022.100737. PMID: 35809836
Cholangiocellular Carcinoma.
Vogel A, Saborowski A
Digestion 2017;95(3):181-185. Epub 2017 Mar 14 doi: 10.1159/000454763. PMID: 28288474
MRI of cholangiocarcinoma.
Jhaveri KS, Hosseini-Nik H
J Magn Reson Imaging 2015 Nov;42(5):1165-79. Epub 2014 Dec 1 doi: 10.1002/jmri.24810. PMID: 25447417
TRANSHEPATIC CHOLANGIOGRAPHY.
BIRCH JR, SHEA J, CURRIE DJ
Can Med Assoc J 1964 Jun 27;90(26):1442-9. PMID: 14158553Free PMC Article

Diagnosis

Pathology of Cholangiocarcinomas.
Guedj N
Curr Oncol 2022 Dec 26;30(1):370-380. doi: 10.3390/curroncol30010030. PMID: 36661679Free PMC Article
How I treat biliary tract cancer.
Lamarca A, Edeline J, Goyal L
ESMO Open 2022 Feb;7(1):100378. Epub 2022 Jan 13 doi: 10.1016/j.esmoop.2021.100378. PMID: 35032765Free PMC Article
Update on the management of cholangiocarcinoma.
Skipworth JR, Keane MG, Pereira SP
Dig Dis 2014;32(5):570-8. Epub 2014 Jul 14 doi: 10.1159/000360507. PMID: 25034290Free PMC Article
Intrahepatic cholangiocarcinoma.
Brown KM, Parmar AD, Geller DA
Surg Oncol Clin N Am 2014 Apr;23(2):231-46. doi: 10.1016/j.soc.2013.10.004. PMID: 24560108Free PMC Article
TRANSHEPATIC CHOLANGIOGRAPHY.
BIRCH JR, SHEA J, CURRIE DJ
Can Med Assoc J 1964 Jun 27;90(26):1442-9. PMID: 14158553Free PMC Article

Therapy

Integrating cytotoxic, targeted and immune therapies for cholangiocarcinoma.
Merters J, Lamarca A
J Hepatol 2023 Mar;78(3):652-657. Epub 2022 Nov 15 doi: 10.1016/j.jhep.2022.11.005. PMID: 36400328
Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians.
Moris D, Palta M, Kim C, Allen PJ, Morse MA, Lidsky ME
CA Cancer J Clin 2023 Mar;73(2):198-222. Epub 2022 Oct 19 doi: 10.3322/caac.21759. PMID: 36260350
The Landmark Series: Hilar Cholangiocarcinoma.
Soares KC, Jarnagin WR
Ann Surg Oncol 2021 Aug;28(8):4158-4170. Epub 2021 Apr 7 doi: 10.1245/s10434-021-09871-6. PMID: 33829358Free PMC Article
Immunotherapy in cholangiocarcinoma.
Al-Rajabi R, Sun W
Curr Opin Gastroenterol 2021 Mar 1;37(2):105-111. doi: 10.1097/MOG.0000000000000715. PMID: 33507028
Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer.
Ma L, Hernandez MO, Zhao Y, Mehta M, Tran B, Kelly M, Rae Z, Hernandez JM, Davis JL, Martin SP, Kleiner DE, Hewitt SM, Ylaya K, Wood BJ, Greten TF, Wang XW
Cancer Cell 2019 Oct 14;36(4):418-430.e6. Epub 2019 Oct 3 doi: 10.1016/j.ccell.2019.08.007. PMID: 31588021Free PMC Article

Prognosis

The role of tumor-infiltrating lymphocytes in cholangiocarcinoma.
Liu D, Heij LR, Czigany Z, Dahl E, Lang SA, Ulmer TF, Luedde T, Neumann UP, Bednarsch J
J Exp Clin Cancer Res 2022 Apr 7;41(1):127. doi: 10.1186/s13046-022-02340-2. PMID: 35392957Free PMC Article
Cholangiocarcinoma: Epidemiology and risk factors.
Khan SA, Tavolari S, Brandi G
Liver Int 2019 May;39 Suppl 1:19-31. Epub 2019 Mar 24 doi: 10.1111/liv.14095. PMID: 30851228
Cholangiocellular Carcinoma.
Vogel A, Saborowski A
Digestion 2017;95(3):181-185. Epub 2017 Mar 14 doi: 10.1159/000454763. PMID: 28288474
Epidemiology of cholangiocarcinoma.
Bergquist A, von Seth E
Best Pract Res Clin Gastroenterol 2015 Apr;29(2):221-32. Epub 2015 Feb 16 doi: 10.1016/j.bpg.2015.02.003. PMID: 25966423
Intrahepatic cholangiocarcinoma.
Brown KM, Parmar AD, Geller DA
Surg Oncol Clin N Am 2014 Apr;23(2):231-46. doi: 10.1016/j.soc.2013.10.004. PMID: 24560108Free PMC Article

Clinical prediction guides

Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma.
Shang T, Jiang T, Lu T, Wang H, Cui X, Pan Y, Xu M, Pei M, Ding Z, Feng X, Lin Y, Li X, Tan Y, Feng F, Dong H, Wang H, Dong L
Front Immunol 2023;14:1166497. Epub 2023 May 10 doi: 10.3389/fimmu.2023.1166497. PMID: 37234171Free PMC Article
Immune checkpoint inhibitors in cholangiocarcinoma.
Beri N
Immunotherapy 2023 May;15(7):541-551. Epub 2023 Apr 25 doi: 10.2217/imt-2022-0288. PMID: 37096964
IgG4-related autoimmune liver disease.
Capurso G, Pedica F, Palumbo D, Della-Torre E
Minerva Gastroenterol (Torino) 2023 Mar;69(1):23-49. Epub 2020 Dec 3 doi: 10.23736/S2724-5895.20.02794-4. PMID: 33267565
The role of tumor-infiltrating lymphocytes in cholangiocarcinoma.
Liu D, Heij LR, Czigany Z, Dahl E, Lang SA, Ulmer TF, Luedde T, Neumann UP, Bednarsch J
J Exp Clin Cancer Res 2022 Apr 7;41(1):127. doi: 10.1186/s13046-022-02340-2. PMID: 35392957Free PMC Article
Histopathology of hepatocellular carcinoma.
Schlageter M, Terracciano LM, D'Angelo S, Sorrentino P
World J Gastroenterol 2014 Nov 21;20(43):15955-64. doi: 10.3748/wjg.v20.i43.15955. PMID: 25473149Free PMC Article

Recent systematic reviews

Circular RNA in cholangiocarcinoma: A systematic review and bibliometric analysis.
Zhou Z, Chen C, Han B, Wang Y, Liu Y, Liu Q, Xu X, Yin Y, Sun B
Pathol Res Pract 2023 Sep;249:154755. Epub 2023 Aug 9 doi: 10.1016/j.prp.2023.154755. PMID: 37651837
Epidemiology, Natural History, and Outcomes of Primary Sclerosing Cholangitis: A Systematic Review of Population-based Studies.
Trivedi PJ, Bowlus CL, Yimam KK, Razavi H, Estes C
Clin Gastroenterol Hepatol 2022 Aug;20(8):1687-1700.e4. Epub 2021 Aug 30 doi: 10.1016/j.cgh.2021.08.039. PMID: 34474162
Meta-analysis of laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma.
Machairas N, Kostakis ID, Schizas D, Kykalos S, Nikiteas N, Sotiropoulos GC
Updates Surg 2021 Feb;73(1):59-68. Epub 2020 Nov 21 doi: 10.1007/s13304-020-00930-3. PMID: 33219937
Liver Transplantation for Intrahepatic Cholangiocarcinoma: A Meta-analysis and Meta-regression of Survival Rates.
Ziogas IA, Giannis D, Economopoulos KP, Hayat MH, Montenovo MI, Matsuoka LK, Alexopoulos SP
Transplantation 2021 Oct 1;105(10):2263-2271. doi: 10.1097/TP.0000000000003539. PMID: 33196623
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
Clements O, Eliahoo J, Kim JU, Taylor-Robinson SD, Khan SA
J Hepatol 2020 Jan;72(1):95-103. Epub 2019 Sep 16 doi: 10.1016/j.jhep.2019.09.007. PMID: 31536748

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Reviews

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...